Terms: = Endocrine gland cancer AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269
38 results:
1. Single-cell RNA-sequencing analysis reveals divergent transcriptome events between platinum-sensitive and platinum-resistant high-grade serous ovarian carcinoma.
Wang Z; Yang L; Su X; Wu X; Su R
J Gene Med; 2023 Oct; 25(10):e3504. PubMed ID: 36994597
[TBL] [Abstract] [Full Text] [Related]
2. High
Li XF; Zhang HB; Huo Y
J Int Med Res; 2022 Nov; 50(11):3000605221135864. PubMed ID: 36366735
[TBL] [Abstract] [Full Text] [Related]
3. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
Zhong J; Xiang D; Ma X
Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
[TBL] [Abstract] [Full Text] [Related]
4. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9.
Zhang Y; Li K; Wang W; Han J
Int J Exp Pathol; 2021 Aug; 102(4-5):209-217. PubMed ID: 34719830
[TBL] [Abstract] [Full Text] [Related]
5. hoxa9-methylated DNA as a diagnostic biomarker of ovarian malignancy.
Faaborg L; Jakobsen A; Waldstrøm M; Petersen CB; Andersen RF; Steffensen KD
Biomark Med; 2021 Oct; 15(15):1309-1317. PubMed ID: 34514844
[No Abstract] [Full Text] [Related]
6. Cell-free DNA is abundant in ascites and represents a liquid biopsy of ovarian cancer.
Werner B; Yuwono N; Duggan J; Liu D; David C; Srirangan S; Provan P; ; DeFazio A; Arora V; Farrell R; Lee YC; Warton K; Ford C
Gynecol Oncol; 2021 Sep; 162(3):720-727. PubMed ID: 34454680
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of hoxa9 methylated ctDNA in ovarian cancer using sense-antisense measurement.
Faaborg L; Fredslund Andersen R; Waldstrøm M; Høgdall E; Høgdall C; Adimi P; Jakobsen A; Dahl Steffensen K
Clin Chim Acta; 2021 Nov; 522():152-157. PubMed ID: 34419462
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms.
Liu JQ; Liao XW; Wang XK; Yang CK; Zhou X; Liu ZQ; Han QF; Fu TH; Zhu GZ; Han CY; Su H; Huang JL; Ruan GT; Yan L; Ye XP; Peng T
BMC Gastroenterol; 2020 Dec; 20(1):415. PubMed ID: 33302876
[TBL] [Abstract] [Full Text] [Related]
9. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract] [Full Text] [Related]
10. Detection of aberrant methylation of hoxa9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract] [Full Text] [Related]
11. Mechanism of miR-210 involved in epithelial-mesenchymal transition of pancreatic cancer cells under hypoxia.
Ni J; Zhou S; Yuan W; Cen F; Yan Q
J Recept Signal Transduct Res; 2019; 39(5-6):399-406. PubMed ID: 31875764
[No Abstract] [Full Text] [Related]
12. Circulating hoxa9-methylated tumour DNA: A novel biomarker of response to poly (ADP-ribose) polymerase inhibition in BRCA-mutated epithelial ovarian cancer.
Rusan M; Andersen RF; Jakobsen A; Steffensen KD
Eur J Cancer; 2020 Jan; 125():121-129. PubMed ID: 31865042
[TBL] [Abstract] [Full Text] [Related]
13. Transcription Factor hoxa9 is Linked to the Calcification and Invasion of Papillary Thyroid Carcinoma.
Jin Y; Kim HK; Lee J; Soh EY; Kim JH; Song I; Chung YS; Choi YJ
Sci Rep; 2019 May; 9(1):6773. PubMed ID: 31043660
[TBL] [Abstract] [Full Text] [Related]
14. Delta tocotrienol in recurrent ovarian cancer. A phase II trial.
Thomsen CB; Andersen RF; Steffensen KD; Adimi P; Jakobsen A
Pharmacol Res; 2019 Mar; 141():392-396. PubMed ID: 30639384
[TBL] [Abstract] [Full Text] [Related]
15. DNA methylation profiling as a tool for testicular germ cell tumors subtyping.
Costa AL; Moreira-Barbosa C; Lobo J; Vilela-Salgueiro B; Cantante M; Guimarães R; Lopes P; Braga I; Oliveira J; Antunes L; Henrique R; Jerónimo C
Epigenomics; 2018 Dec; 10(12):1511-1523. PubMed ID: 30418048
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating hoxa9.
Fu Z; Chen C; Zhou Q; Wang Y; Zhao Y; Zhao X; Li W; Zheng S; Ye H; Wang L; He Z; Lin Q; Li Z; Chen R
Cancer Lett; 2017 Dec; 410():68-81. PubMed ID: 28947139
[TBL] [Abstract] [Full Text] [Related]
17. Annual Report of the Committee on Gynecologic Oncology, Japan Society of Obstetrics and Gynecology: Patient Annual Report for 2014 and Treatment Annual Report for 2009.
Saito T; Takahashi F; Katabuchi H;
J Obstet Gynaecol Res; 2017 Nov; 43(11):1667-1677. PubMed ID: 28892220
[TBL] [Abstract] [Full Text] [Related]
18. Overexpression of microRNA-196b Accelerates Invasiveness of cancer Cells in Recurrent Epithelial Ovarian cancer Through Regulation of Homeobox A9.
Chong GO; Jeon HS; Han HS; Son JW; Lee YH; Hong DG; Park HJ; Lee YS; Cho YL
Cancer Genomics Proteomics; 2017; 14(2):137-141. PubMed ID: 28387653
[TBL] [Abstract] [Full Text] [Related]
19. Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), hoxa9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy.
Pontikakis S; Papadaki C; Tzardi M; Trypaki M; Sfakianaki M; Koinis F; Lagoudaki E; Giannikaki L; Kalykaki A; Kontopodis E; Saridaki Z; Malamos N; Georgoulias V; Souglakos J
Pharmacogenomics J; 2017 Dec; 17(6):506-514. PubMed ID: 27779244
[TBL] [Abstract] [Full Text] [Related]
20. Cumulative methylation alternations of gene promoters and protein markers for diagnosis of epithelial ovarian cancer.
Xing BL; Li T; Tang ZH; Jiao L; Ge SM; Qiang X; OuYang J
Genet Mol Res; 2015 May; 14(2):4532-40. PubMed ID: 25966226
[TBL] [Abstract] [Full Text] [Related]
[Next]